RHOEN-KLINIK.UNSP.ADR 1/2 Capital Reinvestment Ratio

Latest as of December 2024: 0.55x

RHOEN-KLINIK.UNSP.ADR 1/2 capital reinvestment ratio. RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) has a Capital Reinvestment Ratio of 0.55x as of December 2024, meaning it reinvests 1% of its operating cash flow (€127.60 Million) in capital expenditures (€70.40 Million). See RHKU cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.55x
Capex / Operating Cash Flow

Operating Cash Flow

€127.60 Million
EUR

Capital Expenditures

€70.40 Million
EUR

Data as of

Dec 2024
Most recent filing

Capital Reinvestment Ratio of RHOEN-KLINIK.UNSP.ADR 1/2 (2021–2024)

Capital reinvestment ratio of RHOEN-KLINIK.UNSP.ADR 1/2 from 2021 to 2024. This chart tracks RHOEN-KLINIK.UNSP.ADR 1/2's Capital Reinvestment Ratio across 4 annual periods. See RHOEN-KLINIK.UNSP.ADR 1/2 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

RHOEN-KLINIK.UNSP.ADR 1/2 Capital Reinvestment Ratio by Year (2021–2024)

RHOEN-KLINIK.UNSP.ADR 1/2 capital reinvestment ratio by year from 2021 to 2024. For the full cash flow conversion analysis, see cash flow conversion of RHOEN-KLINIK.UNSP.ADR 1/2.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.55x €127.60 Million €70.40 Million ▼ -4.2%
2023 0.58x €109.00 Million €62.80 Million ▼ -40.3%
2022 0.97x €60.30 Million €58.20 Million ▲ +21.0%
2021 0.80x €97.50 Million €77.80 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow